Composition and kit for the treatment of inflammatory bowel diseases
GB0209379D0
Pharmaceutical compositions
GB0209374D0
Composition and method for the inhibition of tissue adhesion
GB0209377D0
Oral formulations and uses
GB0209375D0
Compositions for immunological use
GB0209378D0
Compositions for use in tissue engineering
GB0209376D0
Compositions for the treatment of wounds and damaged dermal tissue
BR0208858A
Effervescent solid matter composition, use thereof, method for treating a mammal suffering from a dermal wound, for treating wound healing of a lactating animal suffering from mastitis and for prophylactic treatment of a lactating animal prone to developing mastitis.
BR0207531A
Aqueous solution for prophylactic treatment of breasts of lactating mammals, and method of prophylactic treatment of breasts of lactating mammals to prevent the onset of mastitis
GB0202882D0
Removing pathogens from water
GB0116967D0
Improvements relating to chitosan
SE0101307D0
Effervescent solid composition used for treating dermal wounds comprises chitosan or component releasing carbon dioxide in acidic environment
AU1746601A
Method of covalent coupling
AU7820500A
The use of a positively charged carbohydrate polymer for the prevention of infection
US6486140B2
Agents, and methods employing them, for the prevention or reduction of tissue adhesion at a wound site
BR9804875A
Use of a composition and procedure for prophylactic or wound healing of lactating animals.
CA2261742A1
The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus
